Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research

C. Bakkers, G.A.A.M. Simkens, I.H.J.T. De Hingh*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Pages (from-to)S206-S213
Number of pages8
JournalJournal of Gastrointestinal Oncology
Volume12
DOIs
Publication statusPublished - 1 Apr 2021

Keywords

  • Systemic therapy
  • cytoreductive surgery (CRS)
  • hyperthermic intraperitoneal chemotherapy (HIPEC)
  • peritoneal metastases (PM)
  • colorectal cancer
  • CONSENSUS MOLECULAR SUBTYPES
  • RESECTABLE LIVER METASTASES
  • COLON-CANCER
  • 1ST-LINE TREATMENT
  • RAS MUTATIONS
  • POSTOPERATIVE COMPLICATIONS
  • CURATIVE TREATMENT
  • RANDOMIZED-TRIAL
  • BRAF MUTATION
  • STAGE-II

Cite this